Ahmed Jehanara, Ward Thomas P, Bursell Sven-Eric, Aiello Lloyd M, Cavallerano Jerry D, Vigersky Robert A
Division of Endocrinology and Metabolism, Howard University Hospital, Washington, DC, USA.
Diabetes Care. 2006 Oct;29(10):2205-9. doi: 10.2337/dc06-0295.
The objective of this study was to determine the sensitivity and specificity of Joslin Vision Network nonmydriatic digital stereoscopic retinal imaging (NMDSRI) as a screening tool in detecting diabetic retinopathy.
We reviewed the records of 244 patients with diabetes who had a dilated funduscopic examination (DFE) and NMDSRI done within 1 year of each other at four locations in the metropolitan Washington, DC, area. The images were transmitted through a local area network to a central reading location where they were graded by a single retinal specialist.
Images of 482 eyes from 243 patients were included in the study. Four images did not transmit, and 35% of the images were not gradable. Of the remaining 311 eyes, there was 86% agreement in the grading between NMDSRI and DFE: 227 eyes with no diabetic retinopathy and 40 eyes with diabetic retinopathy. In 46 eyes (15%) there was a disagreement between gradings made by the two techniques. NMDSRI detected diabetic retinopathy in 35 eyes reported as normal by DFE, and in the remaining 11 eyes, the DFE grade was one grade higher than the NMDSRI grade. Adjudicated nonconcordant examinations were within one grade. In the 76 eyes with diabetic retinopathy, retinal thickness could not be assessed in 17 (21%) eyes. When the NMDSRI result was gradable, the overall sensitivity of NMDSRI was 98% and the specificity was 100% for retinopathy within one grade of the DFE. In the limited number of eyes that had diabetic retinopathy with macular edema (six), agreement with the clinical examination was 100%.
NMDSRI is a sensitive and specific method for the screening and diagnosis of diabetic retinopathy, which may help improve compliance with the standards of eye care for patients with diabetes.
本研究的目的是确定 Joslin 视力网络非散瞳数字立体视网膜成像(NMDSRI)作为检测糖尿病视网膜病变筛查工具的敏感性和特异性。
我们回顾了 244 例糖尿病患者的记录,这些患者在华盛顿特区大都会地区的四个地点,在彼此相隔 1 年内分别进行了散瞳眼底检查(DFE)和 NMDSRI。图像通过局域网传输到一个中央阅片地点,由一名视网膜专科医生进行分级。
本研究纳入了 243 例患者的 482 只眼的图像。4 幅图像未传输,35%的图像无法分级。在其余 311 只眼中,NMDSRI 和 DFE 的分级一致性为 86%:227 只眼无糖尿病视网膜病变,40 只眼有糖尿病视网膜病变。在 46 只眼(15%)中,两种技术的分级存在差异。NMDSRI 在 DFE 报告为正常的 35 只眼中检测到糖尿病视网膜病变,在其余 11 只眼中,DFE 分级比 NMDSRI 分级高一级。经判定不一致的检查结果在一个分级范围内。在 76 只患有糖尿病视网膜病变的眼中,17 只眼(21%)无法评估视网膜厚度。当 NMDSRI 结果可分级时,对于 DFE 分级一级以内的视网膜病变,NMDSRI 的总体敏感性为 98%,特异性为 100%。在少数患有糖尿病性黄斑水肿的眼中(6 只),与临床检查的一致性为 100%。
NMDSRI 是一种用于糖尿病视网膜病变筛查和诊断的敏感且特异的方法,这可能有助于提高糖尿病患者眼部护理标准的依从性。